Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
expected to plan appropriately for their own future career development, which may include networking and submitting funding applications. This is a fixed term post of up to 20-months duration. Main Duties
-
generates the funding for our research by setting out our proposals in high quality applications to public, charitable and industrial funding bodies and disseminates the results of our research by publication
-
the project and the Programme team Contribute to writing bids for research funding Contribute to Departmental/School research-related activities and research-related administration Contribute to enterprise
-
Postdoctoral Affairs, which provides a comprehensive professional development program . The Institute is located in fun, affordable and family-friendly Grand Rapids, MI. Located on the banks of the Grand River
-
The Laboratory of Neural Stem Cells, led by Professor Hongyan Wang, Acting Director of the Neuroscience & Behavioral Disorders Program at Duke-NUS Medical School, Singapore, is seeking talented and
-
Research Fellow (Fusion Shielding Materials) - School of Metallurgy and Materials - 105638 - Grade 7
manufacturers. The successful applicant will have direct access to a range of unique facilities available in the university, with Tokamak Energy and with collaborating international partners. Role Summary Work
-
doctoral degree or equivalent obtained in a country other than Sweden. The date of the doctoral degree must be no more than four years before the application deadline, exceptions are made for e.g. parental
-
management, participation in journal clubs, seminars, research presentations at national and international scientific meetings, and, where applicable, supervision of students conducting projects within
-
the lab Develop AI-powered pipelines for analysis of microendoscopic calcium imaging, confocal fluorescence microscopy, and behavioral videos Lead cross-modality image registration applications Launch new
-
oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor prognosis, and this clinic